Filters
Results: 1 to 15 of 15
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Tempus AI United States | 2 | 646 |
|
PAK1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
PathGroup United States | 73 | 505 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health United States | 1 | 523 |
|
CGC Genetics Unilabs Portugal | 1 | 759 |
|
OnkoSight Advanced Comprehensive Solid Tumor Panel (DNA/RNA) BioReference Health United States | 1 | 523 |
|
OnkoSight Advanced 523 Gene NGS Panel BioReference Health United States | 1 | 523 |
|
Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 523 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Fulgent Genetics United States | 1 | 1 |
|
Results: 1 to 15 of 15
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.